PUBLISHER: 360iResearch | PRODUCT CODE: 2083413

PUBLISHER: 360iResearch | PRODUCT CODE: 2083413

Agricultural Biologicals Testing Market by Product Type, Test Type, Technology, Testing Environment, Crop Type, End User - Global Forecast 2026-2032

PUBLISHED: July 9, 2026

PAGES: 183 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

List of Tables

The Agricultural Biologicals Testing Market is projected to grow by USD 3.34 billion at a CAGR of 11.58% by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 1.55 billion
Estimated Year [2026]	USD 1.72 billion
Forecast Year [2032]	USD 3.34 billion
CAGR (%)	11.58%

Agricultural biologicals testing is becoming a critical assurance layer for biostimulants, biopesticides, biofertilizers, microbial inoculants, botanicals, pheromones, and other nature-derived crop inputs. As growers balance yield protection with soil health, residue management, and regulatory expectations, credible laboratory, greenhouse, and field testing is essential to demonstrate product identity, safety, efficacy, shelf life, compatibility, and agronomic value.

Demand is supported by durable agricultural pressures: FAO has reported that plant pests and diseases can cause 20% to 40% of global crop production losses, while the United Nations projects the global population to reach about 9.7 billion by 2050. These realities are pushing input manufacturers, contract research organizations, regulators, and food value chains toward data-backed biological solutions that can complement integrated pest management, nutrient-use efficiency, and regenerative agriculture programs.

Transformative Shifts in the Agricultural Biologicals Testing Landscape

The agricultural biologicals testing landscape is shifting from simple product screening toward full lifecycle evidence generation. Developers increasingly need strain characterization, metabolite profiling, mode-of-action validation, multi-location efficacy trials, formulation stability studies, and compatibility testing with conventional crop protection products. This reflects a market where biologicals are moving from specialty use cases into row crops, horticulture, protected cultivation, and seed treatment programs.

Regulatory convergence is also shaping testing priorities. The United States, European Union, Brazil, India, China, and other major agricultural economies continue to refine pathways for microbial pesticides, biostimulants, biofertilizers, and low-risk products. At the same time, food companies and retailers are placing stronger emphasis on residue reduction, biodiversity, soil health, and sustainability claims, making independently generated, auditable data a competitive requirement rather than a post-launch formality.

Cumulative Impact of Artificial Intelligence on Testing Programs

Artificial intelligence is improving agricultural biologicals testing by accelerating data interpretation across genomics, phenotyping, formulation analytics, trial imagery, weather records, soil profiles, and yield outcomes. AI-enabled image analytics can support disease scoring and plant vigor assessment, while machine learning models can help identify patterns in microbial performance under different agronomic and environmental conditions. These tools do not replace validated trials, but they can reduce noise, improve trial design, and strengthen evidence quality.

The cumulative impact is most visible in decision support. AI can help prioritize candidate strains, forecast shelf-life risks, optimize field trial site selection, and detect treatment effects that may be missed in conventional analysis. For industry leaders, the strongest applications are those aligned with Good Laboratory Practice, Good Experimental Practice, transparent model governance, and human expert review, because regulatory and buyer confidence still depends on traceable, reproducible data.

Key Regional Insights for Agricultural Biologicals Testing

Asia-Pacific is a dynamic agricultural biologicals testing environment because China, India, Japan, South Korea, Australia, and ASEAN economies combine large cultivated areas with expanding demand for sustainable crop inputs and food security. Regional testing must account for monsoon variability, tropical pest pressure, rice and horticulture systems, smallholder adoption patterns, and country-specific registration requirements.

North America remains a leading hub for agricultural biologicals testing due to its advanced contract research infrastructure, large row-crop acreage, strong seed treatment activity, and mature regulatory processes through agencies such as the U.S. EPA, USDA, and Canadian authorities. Latin America is strategically important because Brazil and Mexico are major agricultural exporters where biological nitrogen fixation, biocontrol, and soil health solutions are increasingly relevant to soybeans, corn, sugarcane, fruits, and vegetables.

Europe is shaped by the European Green Deal, Farm to Fork strategy, and stringent safety and environmental assessment expectations, making robust efficacy, ecotoxicology, and quality documentation essential. The Middle East and Africa are gaining relevance as water scarcity, soil degradation, greenhouse production, and food-import dependency increase interest in stress tolerance, biofertility, and integrated pest management testing across arid and semi-arid production systems.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN presents strong testing potential because rice, plantation crops, tropical fruits, vegetables, and aquaculture-linked food systems require biological products adapted to humid climates, fragmented farm structures, and diverse pest complexes. Trial designs in this group benefit from multi-season validation, local strain performance data, and practical compatibility evidence for grower adoption.

The GCC is more specialized but strategically important, with demand centered on controlled-environment agriculture, salinity stress, water-use efficiency, and high-value produce. The European Union remains one of the most demanding groups for scientific substantiation, particularly as biostimulant and plant protection regulations require clear product categorization, safety evidence, and performance documentation.

BRICS countries represent a large agricultural biologicals testing opportunity because Brazil, Russia, India, China, and South Africa span major grain, oilseed, horticulture, and livestock feed systems. G7 markets offer advanced R&D capabilities, strong quality expectations, and premium food supply chains, while NATO member countries overlap significantly with North American and European regulatory systems where traceability, compliance, and resilient agricultural supply chains are priorities.

Key Country Insights for Agricultural Biologicals Testing

The United States is a major testing market because of its large corn, soybean, cotton, specialty crop, and seed treatment sectors, supported by established EPA and state-level review processes. Canada emphasizes cereal, canola, pulse, and greenhouse systems, while Mexico combines export-oriented horticulture with increasing interest in biological pest management and residue-conscious production.

Brazil is one of the most important countries for agricultural biologicals testing, particularly for soybeans, corn, sugarcane, and biological nitrogen fixation. The United Kingdom, Germany, France, Italy, and Spain are shaped by European regulatory expectations, high-value crops, and strong interest in reduced-risk crop protection. Russia offers demand linked to cereals, oilseeds, and soil fertility, though market access and regulatory navigation require careful planning.

China and India are central to global testing strategies due to scale, food security priorities, and expanding domestic biological input industries. Japan and South Korea prioritize quality, precision agriculture, protected cultivation, and premium horticulture, while Australia requires evidence under variable rainfall, drought stress, biosecurity rules, and broadacre production conditions.

Actionable Recommendations for Industry Leaders

Industry leaders should build testing programs that begin with product characterization and end with commercially relevant performance claims. This means integrating molecular identification, contaminant screening, viable count or active ingredient quantification, formulation stability, shelf-life validation, crop safety, dose response, and multi-location efficacy trials before broad commercialization.

Companies should also design trials around real grower decisions. Biologicals often perform differently across soil types, climate zones, crop stages, and input programs, so testing should include conventional and regenerative management systems, compatibility with fertilizers and pesticides, and clear economic endpoints such as yield, quality, nutrient efficiency, or disease reduction. Leaders that combine regulatory-grade evidence with practical agronomic messaging will be better positioned to earn grower, distributor, and retailer trust.

Research Methodology for Evidence-Based Market Intelligence

A robust research methodology for agricultural biologicals testing combines primary evidence, secondary intelligence, and validated analytical frameworks. Primary inputs include interviews with product developers, contract research organizations, agronomists, regulatory specialists, distributors, and growers. Secondary research should draw from recognized public sources such as FAO, OECD-FAO, USDA, EPA, EFSA, national agriculture ministries, peer-reviewed journals, and official regulatory guidance.

Testing methodology should use controlled laboratory assays, greenhouse screening, statistically powered field trials, and post-trial analytics. Data should be assessed for repeatability, environmental interaction, treatment effect size, crop safety, and commercial relevance. Where AI or digital phenotyping is used, models should be documented, outputs should be reviewed by subject-matter experts, and conclusions should remain tied to transparent experimental design.

Conclusion: Evidence Will Define the Next Phase of Biologicals Growth

Agricultural biologicals testing is moving from a support service to a strategic growth enabler for the biological inputs industry. As biological products expand into mainstream crop programs, the winners will be organizations that can prove consistent performance, regulatory readiness, safety, and fit within integrated crop management systems.

The next phase will reward high-quality science, regional trial depth, digital analytics, and credible claims. Organizations that invest in rigorous testing infrastructure, partner with qualified research networks, and align evidence generation with grower economics will be best positioned to support demand in sustainable agriculture, low-residue food production, and climate-resilient farming.

Product Code: MRR-43539E5D2E77

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
4.4. Porter's Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Agricultural Biologicals Testing Market, by Product Type

7.1. Biofertilizers
- 7.1.1. Azotobacter
- 7.1.2. Phosphate Solubilizing Bacteria
- 7.1.3. Rhizobium
7.2. Biopesticides
- 7.2.1. Biochemical
- 7.2.2. Botanical
- 7.2.3. Microbial
7.3. Biostimulants
- 7.3.1. Humic Substances
- 7.3.2. Protein Hydrolysates
- 7.3.3. Seaweed Extracts

8. Agricultural Biologicals Testing Market, by Test Type

8.1. Analytical Testing
- 8.1.1. Composition Analysis
- 8.1.2. Contaminant Screening
8.2. Field Trials
- 8.2.1. Efficacy Testing
- 8.2.2. Environmental Impact Studies
8.3. Regulatory Compliance Testing

9. Agricultural Biologicals Testing Market, by Technology

9.1. Chromatography
9.2. Spectroscopy
9.3. Residue & Metabolite Detection
9.4. PCR-Based Diagnostics
9.5. Next-Generation Sequencing

10. Agricultural Biologicals Testing Market, by Testing Environment

10.1. Laboratory-Based
10.2. Semi-Controlled
10.3. Open Field

11. Agricultural Biologicals Testing Market, by Crop Type

11.1. Cereals & Grains
11.2. Fruits & Vegetables
11.3. Oilseeds & Pulses
11.4. Turf & Ornamentals

12. Agricultural Biologicals Testing Market, by End User

12.1. Agricultural Contractors
12.2. Farmers
12.3. Research Institutes

13. Agricultural Biologicals Testing Market, by Region

13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa

14. Agricultural Biologicals Testing Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Agricultural Biologicals Testing Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. Competitive Landscape

16.1. Market Concentration Analysis, 2025
- 16.1.1. Concentration Ratio (CR)
- 16.1.2. Herfindahl Hirschman Index (HHI)
16.2. Recent Developments & Impact Analysis, 2025
16.3. Product Portfolio Analysis, 2025
16.4. Benchmarking Analysis, 2025

17. Company Profiles

17.1. Agilent Technologies Inc
17.2. ALS Limited
17.3. Anadiag Group
17.4. Applus Servicios Tecnologicos S.L.U.
17.5. AsureQuality Limited
17.6. Bionema Limited
17.7. Biotecnologie B.T Srl
17.8. Bureau Veritas SA
17.9. Eurofins Scientific SE
17.10. Fera Science Ltd
17.11. i2LResearch
17.12. Intertek Group plc
17.13. JRF India
17.14. Koppert Biological Systems B.V.
17.15. LAUS GmbH
17.16. Microbac Laboratories Inc
17.17. Merieux NutriSciences Corporation
17.18. Noack Group
17.19. Pace Analytical Services LLC
17.20. RJ Hill Laboratories Limited
17.21. SGS SA
17.22. Staphyt SA
17.23. SynTech Research Group
17.24. TUV NORD GROUP
17.25. TUV SUD AG